| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 239463-95-7 | 4,5,5,6,6,6-Hexafluoro-4-(trifluoromethyl)hexanoic acid | C7H5F9O2 |
| 239466-74-1 | Prasugrel metabolite | C18H20FNO3S |
| 239476-24-5 | 9,9,9',9',9'',9''-Hexamethyl-N,N'-bis(3-methylphenyl)-N,N'-diphenyl-[2,2':7',2''-ter-9H-fluorene]-7,7''-diamine | C71H60N2 |
| 239482-98-5 | 2-(Aminoethyl)-1-N-Boc-piperidine | C12H24N2O2 |
| 239483-09-1 | tert-Butyl (2S)-2-(2-aminoethyl)-1-pyrrolidinecarboxylate | C11H22N2O2 |
| 239783-48-3 | 6-Iodo-2-tetralone | C10H9IO |
| 239791-63-0 | 3-Bromo-6-chloro-2-ethoxy-5-nitropyridine | C7H6BrClN2O3 |
| 239795-57-4 | 3,4,4,5,5,5-Hexafluoro-3-(trifluoromethyl)-1-pentene | C6H3F9 |
| 239807-03-5 | Voriconazole Impurity 8 | C16H14F3N5O |
| 239807-04-6 | Voriconazole Impurity 7 | C16H14F3N5O |
| 240116-21-6 | L-Seryl-L-prolyl-L-arginyl-L-tryptophyl-L-tryptophyl-L-prolyl-L-threonyl-L-cysteinyl-L-leucine | C54H76N14O12S |
| 240122-30-9 | Griffithazanone A | C14H11NO4 |
| 240122-32-1 | Griffithinam | C17H13NO4 |
| 240401-09-6 | N-Boc-1-oxa-8-azaspiro[4.5]decan-3-ol | C13H23NO4 |
| 240401-22-3 | 4-Cyanopiperidine hydrochloride | C6H10N2.HCl |
| 240401-27-8 | 2-Oxa-7-azaspiro[3.5]nonane-7-carboxylic acid tert-butyl ester | C12H21NO3 |
| 240409-02-3 | alpha-Amino-2,4-difluorobenzeneacetic acid | C8H7F2NO2 |
| 240417-00-9 | 2-Diphenylphosphino-2'-(N,N-dimethylamino)biphenyl | C26H24NP |
| 240423-23-8 | (±)-Salvicine | C20H26O4 |
| 240423-53-4 | N-[(1R,2S)-2-(Acetyloxy)-1-methyl-2-phenylethyl]-2,4,6-trimethyl-N-(phenylmethyl)benzenesulfonamide | C27H31NO4S |
| 240423-74-9 | N-[(1S,2R)-2-(Acetyloxy)-1-methyl-2-phenylethyl]-2,4,6-trimethyl-N-(phenylmethyl)benzenesulfonamide | C27H31NO4S |
| 240490-00-0 | 2-(Trifluoromethyl)phenylglycine | C9H8F3NO2 |
| 240494-70-6 | Matofluthrin | C18H20F4O3 |
| 240800-45-7 | 5-Fluoro-2-(trifluoromethyl)benzonitrile | C8H3F4N |
| 240800-48-0 | 2,3,5-Trifluorobenzoyl chloride | C7H2ClF3O |
| 240816-28-8 | 2-(Ethoxy)-4-(trimethylstannyl)thiazole | C17H33NOSSn |
| 240816-34-6 | 4-Bromo-2-ethoxythiazole | C5H6BrNOS |
| 240816-35-7 | 4-Bromo-2-methoxythiazole | C4H4BrNOS |
| 241125-75-7 | Sibiricose A6 | C23H32O15 |
| 241125-76-8 | Sibiricaxanthone A | C24H26O14 |
| 241125-81-5 | Sibiricaxanthone B | C24H26O14 |
| 241129-90-8 | 7-(beta-D-Glucopyranosyloxy)-3-(3-hydroxy-5-methoxyphenyl)-4H-1-benzopyran-4-one | C22H22O10 |
| 241153-84-4 | Castor oil monomaleate | |
| 241154-09-6 | 2,3,5-Trifluorobenzonitrile | C7H2F3N |
| 241157-04-0 | Hexadecanoic-d31 acid 1,2,3-propanetriyl ester | C51H5D93O6 |
| 241157-06-2 | Hexadecanoic-2,2-d2 acid 1,2,3-propanetriyl ester | C51H92D6O6 |
| 241479-67-4 | Isavuconazole | C22H17F2N5OS |
| 241479-72-1 | (2R,3R)-2-(2,5-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2,3-butanediol | C12H13F2N3O2 |
| 241479-73-2 | 1-[[(2R,3S)-2-(2,5-Difluorophenyl)-3-methyloxiranyl]methyl]-1H-1,2,4-triazole | C12H11F2N3O |
| 241479-74-3 | (alphaS,betaR)-beta-(2,5-Difluorophenyl)-beta-hydroxy-alpha-methyl-1H-1,2,4-triazole-1-butanenitrile | C13H12F2N4O |
| 241479-75-4 | (alphaR,betaR)-beta-(2,5-Difluorophenyl)-beta-hydroxy-alpha-methyl-1H-1,2,4-triazole-1-butanamide | C13H14F2N4O2 |
| 241479-80-1 | 1-[[(2R,3S)-3-Methyl-2-(2,4,5-trifluorophenyl)oxiranyl]methyl]-1H-1,2,4-triazole | C12H10F3N3O |
| 241479-84-5 | 4-(N-tert-Butoxycarbonyl-N-methylaminoacetoxy)-3,5-dimethylbenzyl bromide | C17H24BrNO4 |
| 241800-98-6 | Zoniporide | C17H16N6O |
| 241820-91-7 | 2-Oxa-7-azaspiro[3.5]nonane | C7H13NO |
| 242132-61-2 | Azelamide monoethanolamine | C11H21NO4 |
| 242138-07-4 | Omalizumab | |
| 242459-44-5 | (2S)-2-Cyano-1-piperidinecarboxylic acid tert-butyl ester | C11H18N2O2 |
| 242474-49-3 | 2-Methyl-4-(1-methylethyl)-3-pyridinecarbonitrile | C10H12N2 |
| 242475-26-9 | alpha-Amino-3-(trifluoromethyl)benzeneacetic acid | C9H8F3NO2 |